3559 results for «286»
3559 results
How to optimise peri-PCI antiplatelet treatment in clinical practice? Novel evidence on cangrelor
17 May 2023 – From EuroPCR 2023
Discover the optimal approach to peri-percutaneous coronary intervention (PCI) antiplatelet treatment in clinical practice with a focus on the novel agent cangrelor. Gain a deeper understanding of the rationale behind cangrelor's use in various PCI settings, learn about the current recommendations and practices for its administration...
Ultra-low contrast PCI - An indispensable toolset in complex coronary interventions and higher-risk patients
17 May 2023 – From EuroPCR 2023
Discover the indispensable toolset of ultra-low contrast (ULC) percutaneous coronary intervention (PCI) in complex coronary interventions and higher-risk patients in this session. Gain a comprehensive understanding of how ULC PCI can enhance the safety and quality of revascularization in complex procedures and learn practical aspects from...
Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform
16 May 2023 – From EuroPCR 2023
What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...
Tailored device choice and implant technique to optimise TAVI procedural outcomes
17 May 2023 – From EuroPCR 2023
Discover the key factors to consider in selecting the optimal valve and implant technique for transcatheter aortic valve implantation (TAVI) to achieve optimal procedural outcomes. Gain insights into the impact of device choice and implantation technique on coronary access following TAVI and learn valuable strategies for...
EuroPCR 2023 Welcome Ceremony
16 May 2023 – From EuroPCR 2023
As we celebrate the 30th anniversary of primary PCI for STEMI this year, follow the retrospective of this major advance in interventional cardiology, before listening to William Wijns, Jean Fajadet and their guests take stock of the current STEMI care worldwide at this opening ceremony which launches...
Heterotopic valve replacement for patients with right heart failure and tricuspid regurgitation - All you need to know!
17 May 2023 – From EuroPCR 2023
Discover the comprehensive guide to heterotopic valve replacement for patients experiencing right heart failure and tricuspid regurgitation. Join this session to gain insights into patient selection criteria, delve into the concept behind this innovative procedure, and grasp the fundamental aspects of its execution.
The 2023 top Japanese abstracts
18 Feb 2023 – From PCR Tokyo Valves 2023
Explore the cutting-edge research showcased in the top Japenese abstracts of PCR Tokyo Valves 2023. Uncover profound insights, including a detailed examination of three-year outcomes in 500 patients treated with MitraClip, a comparative analysis of outcomes between COMBO therapy and transcatheter edge-to-edge repair for severe mitral...
TAVI and difficult anatomy
18 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session to discover how TAVI techniques helped cases of complex anatomy, such as: extremely horizontal aorta patient treated with snare-assisted TAVI technique, a novel simplified pacing-over-the-wire technique, successful non-contrast TAVI, and much more!
Structural heart disease intervention focusing on co-medical roles - Multidisciplinary approach in Japanese style
18 Feb 2023 – From PCR Tokyo Valves 2023
In this session, discover the intricacies of decision-making and a holistic strategy in structural heart disease intervention (in Japenese). Explore interdisciplinary collaboration and evaluate the adequacy of routine work through cases exploring TAVI, MitraClip, and LAAC.
TAVI and complex coronary artery anatomy
18 Feb 2023 – From PCR Tokyo Valves 2023
What defines 'complex TAVI and coronary artery scenarios'? Join this session to discover when chimney stenting for threatening left coronary artery obstruction becomes the ideal alternative, using balloon-assisted BASILICA for valve-in-valve TAVR, and addressing tissue embolisation post-TAVI.
Mutual understanding of essential roles of co-medical staff supporting structural heart disease intervention
18 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session in japanese to learn more about the essential roles of co-medicals in structural heart disease intervention: the decision-making regarding the treatment and imaging procedure, strategies and evaluating effects and complications.
Mitral valve interventions
18 Feb 2023 – From PCR Tokyo Valves 2023
Discover various compelling mitral valve interventions in this session: newer vs. older generations of the MitraClip devices, safety and feasibility of balloon mitral valvotomy, catheter ablation efficacy, and more!
Unraveling aortic valve complexities: grading challenges, intervention decisions, and advanced imaging techniques
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore the complexities of aortic valve disorders in this PCR Imaging Valves Madrid 2024 session, covering topics from grading challenges to intervention decisions in both asymptomatic and symptomatic patients, and learn more about advanced imaging techniques for quantifying aortic regurgitation severity and navigating treatment choices for...
The aortic regurgitation problem: an imaging and practical perspective
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this session, discover strategies to address biases in aortic regurgitation, influenced by factors like etiology, natural history, surgical risk, age, and gender, and explore an imaging-centric approach to better quantify aortic regurgitation and comprehend its relationship with left ventricular remodeling and outcomes. Anticipate forthcoming guidelines...
Welcome to GulfPCR Valves 2023
05 Dec 2023 – From GulfPCR-GIM 2023
Find out more about this very first edition of GulfPCR Valves by discovering its Course directors, its objectives, its programme, its partners and its interactivity. If you are a heart valve interventionist or an imager, and you have a keen interest in valve disease, and TAVI in...
TAVI for bicuspid aortic stenosis patients - Recorded cases
05 Dec 2023 – From GulfPCR-GIM 2023
Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.
- An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
TAVI and access: alternating is wise
16 Jan 2024 – From GulfPCR-GIM 2023
Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...
Newer generation self-expanding platform: technical optimisation for common clinical challenges
05 Dec 2023 – From GulfPCR-GIM 2023
The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...
Essentials of lifetime management of TAVR patients using novel Myval THV
05 Dec 2023 – From GulfPCR-GIM 2023
Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...
Evidence gap and new indications
05 Dec 2023 – From GulfPCR-GIM 2023
Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...
